Arcutis Biotherapeutics, Inc.: Form 8-K, filed Sep 27, 2023
Filed with the SEC on Sep 27, 2023 and accepted by EDGAR at Sep 27, 2023, 16:30 ET.
Items reported
- Item 5.02 Departure or appointment of officers or directors
- Item 7.01 Regulation FD disclosure
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001787306-23-000109. Last ingested by Listed: Oct 28, 2026, 09:04 ET. Listed shows no prices and gives no investment advice.